Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Resolved 12 November 2026Incoming appointee
2 itemsScheduled Appointment Date1 January 2027
Ota Hideyuki (太田 秀幸)
Previous positionDirector, Representative Director and President of ㈱アルプスケアハート
New positionRepresentative Director and President, ㈱アルプスケアハート
Shimizu Naoto (清水 直人)
Previous positionHead of Central Japan Business Division
New positionExecutive Officer, Head of Central Japan Business Division
Date of birth19 November 1972
Year joined the company1995
Number of shares held114,330 shares (as of 30 June 2026)
Because the names and counts do not correspond, they are shown as reported without linking the counts to individual names.Departing officer
1 itemDate of departure1 January 2027
Sudo Taishi (須藤 泰志)Next role stated
Former PositionRepresentative director and president
New positionAdviser, Representative Director and President of ㈱DONKEY
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors and will change from director to adviser.
Directors after the change7Number
Reason for change
This is intended to rejuvenate management and further strengthen and enhance the management structure, with the aim of increasing the corporate value of the Group toward its 60th anniversary in 2028.
| Item | Details |
|---|---|
| Resolution date | 12 November 2026 |
| Scheduled Appointment Date | 1 January 2027 |
| Date of departure | 1 January 2027 |
| Name of appointee | Ota Hideyuki (太田 秀幸), Shimizu Naoto (清水 直人) |
| Appointee's new position | Representative Director and President, ㈱アルプスケアハート, Executive Officer, Head of Central Japan Business Division |
| Appointee's previous position | Director, Representative Director and President of ㈱アルプスケアハート, Head of Central Japan Business Division |
| Appointee's date of birth | 19 November 1972 |
| Year the appointee joined the Company | 1995 |
| Number of shares held by the appointee | 114,330 shares (as of 30 June 2026) |
| Name of departing officer | Sudo Taishi (須藤 泰志) |
| Former position of departing officer | Representative director and president |
| New position of departing officer | Adviser, Representative Director and President of ㈱DONKEY |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors and will change from director to adviser. |
| Reason for change | This is intended to rejuvenate management and further strengthen and enhance the management structure, with the aim of increasing the corporate value of the Group toward its 60th anniversary in 2028. |
| Number of directors after the change | 7 directors (including 3 outside directors) |
Items this document does not state (6)
Reason for departureReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To rejuvenate management and further strengthen and enhance the management structure, with the aim of increasing the corporate value of the Group toward its 60th anniversary in 2028.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.